blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0356595

EP0356595 - Novel peptidase inhibitors [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.03.1991
Database last updated on 03.10.2024
Most recent event   Tooltip13.03.1991Application deemed to be withdrawnpublished on 02.05.1991 [1991/18]
Applicant(s)For all designated states
MERRELL DOW PHARMACEUTICALS INC.
2110 East Galbraith Road, P.O. Box 156300 Cincinnati
Ohio 45215-6300 / US
[N/P]
Former [1990/10]For all designated states
MERRELL DOW PHARMACEUTICALS INC.
2110 East Galbraith Road, P.O. Box 156300
Cincinnati Ohio 45215-6300 / US
Inventor(s)01 / Schirlin, Daniel
12 rue Jean-Jacques Rousseau Hoenheim
F-67800 Bischheim / FR
02 / Pelton, John Tom
3, rue Murner
F-67000 Strasbourg / FR
03 / Tarnus, Céline
43, rue du 22 Novembre
F-67000 Strasbourg / FR
04 / Jung, Michel
3, Place Echauffour Engwiller
F-67350 Pfaffenhoffen / FR
[1990/10]
Representative(s)Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cédex 07 / FR
[N/P]
Former [1990/10]Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
F-75340 Paris Cédex 07 / FR
Application number, filing date88402205.401.09.1988
[1990/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0356595
Date:07.03.1990
Language:EN
[1990/10]
Search report(s)(Supplementary) European search report - dispatched on:EP20.04.1989
ClassificationIPC:C07K5/02, C07K5/06, C07K5/08, C07K5/10, A61K37/00
[1990/10]
CPC:
C07D233/54 (EP); C07K7/06 (KR); A61P43/00 (EP);
C07C233/36 (EP); C07C233/40 (EP); C07C233/78 (EP);
C07C235/74 (EP); C07C237/10 (EP); C07C271/18 (EP);
C07C271/20 (EP); C07C271/22 (EP); C07C271/28 (EP);
C07C279/14 (EP); C07K5/021 (EP); C07K5/0227 (EP);
C07K5/0827 (EP); C07K5/1027 (EP) (-)
Designated contracting statesFR [1990/10]
TitleGerman:Peptidase-Hemmer[1990/10]
English:Novel peptidase inhibitors[1990/10]
French:Inhibiteurs des peptidases[1990/10]
File destroyed:04.03.1999
Examination procedure08.09.1990Application deemed to be withdrawn, date of legal effect  [1991/18]
04.12.1990Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [1991/18]
Fees paidPenalty fee
Penalty fee Rule 85b EPC 1973
03.10.1990M01   Not yet paid
Additional fee for renewal fee
01.10.199003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0187721  (DU PONT [US]);
 [X]EP0275101  (MERRELL DOW PHARMA [US])
 [Y]  - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 85, no. 18, September 1988pages 6612-6616; S. SEELMEIER et al.: "Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A"
 [Y]  - CHEMICAL ABSTRACTS, vol. 107, no. 23, 7th December 1987, page 274, abstract no. 214141y, Columbus, Ohio, US; L.H. PEARL et al.: "A structural model for the retroviral proteases", & NATURE (LONDON) 1987, 329(6137)351-4
 [Y]  - CHEMICAL ABSTRACTS, vol. 107, no. 25, 21st December 1987, page 368, abstract no. 231968r, Columbus, Ohio, US; I. KATOH et al.: "Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor", & NATURE (LONDON) 1987, 329(6140)654-6
 [A]  - BIOLOGICAL ABSTRACTS, vol. 86, 1988, abstract no. 86065299, Philadelphia, PA., US; M. KOTLER et al.: "Synthetic peptides as substrates and inhibitors of a retroviral protease", & PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA(US) 1988, vol. 85, no. 12p4185-4189
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.